Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer.
Bryce
Cicely
C
Kennecke
Hagen
H
Chia
Stephen
S
Ragaz
Joseph
J
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*
D000972:Antineoplastic Agents, Phytogenic; D011960:Receptors, Estrogen; D017239:Paclitaxel